ArticleBMC pulmonary medicine2025

Amivantamab versus standard therapies among patients with advanced non-small cell lung cancer and epidermal growth factor receptor exon 20 insertion mutations after platinum-based therapy in China.

Lan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.